Your session is about to expire
← Back to Search
Health Services Intervention for PTSD
N/A
Waitlist Available
Led By Nicholas Holder, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with PTSD as part of an intake assessment at the San Francisco Veterans Affairs Medical Center.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial will explore how different sequences of psychosocial and medication treatments affect a Veteran's likelihood of initiating cognitive processing therapy or prolonged exposure therapy for PTSD, with the goal of developing an intervention to improve timely transition to these evidence-based treatments.
Who is the study for?
This trial is for Veterans diagnosed with PTSD at the San Francisco Veterans Affairs Medical Center. Participants must be able to give informed consent and understand study materials. Those with cognitive impairments or active psychosis cannot join.Check my eligibility
What is being tested?
The study is examining how different treatment sequences affect starting recommended PTSD therapies like Cognitive Processing Therapy (CPT) or Prolonged Exposure Therapy (PE). It includes developing a new health service intervention to help transition into these therapies.See study design
What are the potential side effects?
Since this trial involves standard treatments and a health services intervention, side effects may vary based on individual experiences but are not specified as drug-related in the provided information.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was diagnosed with PTSD at the San Francisco Veterans Affairs Medical Center.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Initiation of Recommended PTSD Treatment
Secondary outcome measures
Acceptability (Discontinuation of Mental Health Treatment without Provider Concurrence)
Limited Efficacy Testing (PTSD Symptom Severity)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: New Health Services InterventionExperimental Treatment1 Intervention
Novel health services intervention with a VA mental health treatment coordinator
Group II: TAUActive Control1 Intervention
Treatment As Usual with a VA mental health treatment coordinator
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,563 Total Patients Enrolled
White River Junction Veterans Affairs Medical CenterFED
28 Previous Clinical Trials
16,841 Total Patients Enrolled
Nicholas Holder, PhDPrincipal InvestigatorSan Francisco VA Medical Center, San Francisco, CA
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I understand the study materials.I was diagnosed with PTSD at the San Francisco Veterans Affairs Medical Center.You are currently experiencing severe mental illness that may affect your ability to participate in the study.The study is only open to military veterans.
Research Study Groups:
This trial has the following groups:- Group 1: TAU
- Group 2: New Health Services Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there capacity to involve new participants in this experiment?
"According to the information on clinicaltrials.gov, this investigation is not currently in recruitment mode. It was first published June 1st 2023 and last updated November 21st 2022. However, 411 other scientific trials are presently open for participants."
Answered by AI
Who else is applying?
What portion of applicants met pre-screening criteria?
Did not meet criteria
Share this study with friends
Copy Link
Messenger